JOHANNA GORDON: Open Payments
NPI 1083213037 · GLENVIEW, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,016 in 66 payments from 16 companies in 2025. Trend: 2023 $1,081 · 2024 $975 · 2025 $2,016
Food & beverage: $2,016
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 1 | $391 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $340 |
| AstraZeneca Pharmaceuticals LP | 14 | $334 |
| Novartis Pharmaceuticals Corporation | 11 | $305 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $216 |
| E.R. Squibb & Sons, L.L.C. | 3 | $70 |
| Novo Nordisk Inc | 2 | $55 |
| SCPHARMACEUTICALS INC. | 2 | $55 |
| Amgen Inc. | 3 | $49 |
| PFIZER INC. | 2 | $41 |
Products named: Rapiblyk, Kerendia, LEQVIO, JARDIANCE, FARXIGA, WAINUA, CAMZYOS, Wegovy.
Industry payments across IL — which companies pay providers there.
